Application of competition theory to tumour growth: implications for tumour biology and treatment.

To assess critical parameters controlling tumour growth and response to therapy, competition theory models the tumour-host interface as a network of interacting normal and malignant cell populations using coupled, non-linear differential equations. When the equations are analysed under conditions which simulate tumour development, three phases of tumour growth, each with different critical parameters, can be predicted. Transitions between these phases correspond to the initiation, promotion and invasion stages demonstrated in experimental models of carcinogenesis. Critical cellular properties for each transition are predicted including phenomena already demonstrated experimentally such as the linkage of invasive tumour growth with acquisition of angiogenesis. The model also predicts the previously unknown phenomenon of "functional equivalence" in which disparate tumour traits can play identical roles in tumour growth and invasion. This approach allows the diverse but inconsistent properties of transformed cells to be understood according to their specific contribution to tumorigenesis. The models have significant implications for treatment strategies.

[1]  D. McEachern,et al.  Growth regulation of mouse mammary tumor cells in collagen gel cultures by diffusible factors produced by normal mammary gland epithelium and stromal fibroblasts. , 1989, Cancer research.

[2]  D. Hanahan,et al.  Switch to the angiogenic phenotype during tumorigenesis. , 1991, Princess Takamatsu symposia.

[3]  L. Amundadottir,et al.  Growth factors in breast cancer: Mitogenesis to transformation , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[4]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[5]  Shymko Rm,et al.  Cellular and geometric control of tissue growth and mitotic instability. , 1976 .

[6]  A. Rigas Spectra-based estimates of certain time-domain parameters of a bivariate stationary-point process. , 1991, Mathematical biosciences.

[7]  F. Schröder,et al.  Endocrine therapy for prostate cancer: recent developments and current status. , 1993, British journal of urology.

[8]  T. Wheldon Mitotic autoregulation of normal and abnormal cells: alternative mechanisms for the derangement of growth control. , 1975, Journal of theoretical biology.

[9]  Walter J. Coulson,et al.  The rate of growth and apparent duration of untreated primary bronchial carcinoma , 1963, Cancer.

[10]  Bishop Jm The molecular genetics of cancer: 1988. , 1988 .

[11]  Laird Ak Dynamics of Tumour Growth: Comparison of Growth Rates and Extrapolation of Growth Curve to One Cell , 1965 .

[12]  G. Gibson,et al.  Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. , 1989, Cancer research.

[13]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[14]  J. Geller Basis for hormonal management of advanced prostate cancer , 1993, Cancer.

[15]  D. Neal,et al.  Evaluation of epidermal growth factor receptors in bladder tumours. , 1987, British Journal of Cancer.

[16]  B. Zetter,et al.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. , 1989, The Journal of clinical investigation.

[17]  J. Leith,et al.  Interlocking triads of growth control in tumors. , 1995, Bulletin of mathematical biology.

[18]  Kathleen R. Cho,et al.  Genetic alterations in the adenoma–carcinoma sequence , 1992, Cancer.

[19]  R. Weinberg,et al.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.

[20]  R. M. Hicks,et al.  Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder. , 1977, Cancer research.

[21]  R. Clarke,et al.  The process of malignant progression in human breast cancer. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[23]  M. Nowak,et al.  Oncogenes, anti-oncogenes and the immune response to cancer : a mathematical model , 1992, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[24]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[25]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[26]  D. Summers,et al.  Disturbed nonlinear multispecies models in ecology. , 1991, Mathematical biosciences.

[27]  J. Bishop The molecular genetics of cancer. , 1987, Science.

[28]  L. Ossowski Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase. , 1992, Cancer research.

[29]  F. Albrecht,et al.  The dynamics of two interacting populations , 1974 .

[30]  I. Fidler,et al.  Biological diversity in metastatic neoplasms: origins and implications. , 1982, Science.

[31]  R. Gatenby,et al.  Population ecology issues in tumor growth. , 1991, Cancer research.

[32]  P. Chambon,et al.  A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas , 1990, Nature.

[33]  S. Yuspa The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis--thirty-third G. H. A. Clowes Memorial Award Lecture. , 1994, Cancer research.

[34]  T. Stamey,et al.  Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts , 1989, The Prostate.

[35]  J. Shirlaw THE METABOLISM OF TUMOURS , 1931 .

[36]  T. Hurskainen,et al.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.

[37]  N. Rosen,et al.  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. , 1991, Cancer research.

[38]  B. Angus,et al.  Epidermal growth factor receptor status of histological sub-types of breast cancer. , 1988, British Journal of Cancer.

[39]  M. Herlyn,et al.  Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R. Huebner,et al.  Alterations in the characteristics of sugar uptake by mouse cells transformed by murine sarcoma viruses. , 1969, Journal of the National Cancer Institute.

[42]  Elliott W. Montroll,et al.  Nonlinear Population Dynamics. (Book Reviews: On the Volterra and Other Nonlinear Models of Interacting Populations) , 1971 .

[43]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[44]  J G Klijn,et al.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. , 1992, Endocrine reviews.